Kamis, 17 Mei 2012

Google Algorithm Finds Cancer Biomarkers

Google Algorithm Finds Cancer Biomarkers

Editor's Choice
Main Category: Cancer / Oncology
Article Date: 17 May 2012 - 14:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions   <!-- rate icon rate article
Patient / Public:not yet rated

Healthcare Prof:not yet rated


Seven proteins that can help physicians evaluate how aggressive a patient's cancer is and whether or not they should receive chemotherapy have been identified by German researchers.

Using a strategy similar to Google's PageRank algorithm, the researchers from Dresden University of Technology, Germany, were able to rank around 20,000 proteins by their genetic relevance to the progression of pancreatic cancer. The study is published in PLoS Computational Biology.

The team used their own version of the Google algorithm in order to identify new biomarkers, which are molecules produced by cancer cells. Although biomarkers can help physicians detect cancer earlier, they are often difficult to find and time consuming. In addition, biomarkers found in different studies for the same types of cancer almost never overlap.

However, the team was able to avoid this problem by using the Google strategy. The researchers made use of the fact that proteins in a cell are linked via a network of physical and regulatory interactions; the 'protein Facebook' so to speak.

Christof Winter explained:

"Once we added the network information in our analysis, our biomarkers became more reproducible."

Using the Google algorithm and this network information the researchers found a considerable overlap with a previous study from the University of North Carolina. In this overlap, the researchers were able to identify a protein which can evaluate aggressiveness in pancreatic cancer.

Before these new biomarkers can be used in clinical practice they need to be validated in a larger follow-up study. However, one problem remains - how to turn these insights into new medications which slow down cancer progression. A clinical trial on a pancreas cancer drug is currently being conducted by the team together with the Dresden-based biotech company RESprotect.

Written By Grace Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Google Algorithm Finds Cancer Biomarkers'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Everyday Health Network back to top | home | privacy policy

MediLexicon International Ltd Logo MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Tidak ada komentar:

Posting Komentar